Evaxion Biotech

+$0.09 (+5.00%) Today
-$0.03 (-1.59%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EVAX and other ETFs, options, and stocks.

About EVAX

Evaxion Biotech A/S engages in the discovery and development of novel immunotherapies for cancer and infectious diseases. It uses its proprietary AI technology, engineering expertise and drug development know-how to simulate the human immune system and generate predictive models to identify and develop efficacious immunotherapies for patients in the global market.

CEO
Lars Aage Staal Wegner
Employees
61
Headquarters
Hoersholm, North Denmark
Founded
2008

EVAX Key Statistics

Market cap
43.86M
Price-Earnings ratio
—
Dividend yield
—
Average volume
70.65K
High today
$1.88
Low today
$1.76
Open price
$1.76
Volume
30.01K
52 Week high
$25.04
52 Week low
$1.51

EVAX Earnings

-$0.39
-$0.26
-$0.13
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure